Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Russo

Showing results (341-350 of 357) with videos related to

Pageof 36
Sort By:
European Urology Focus|October 26, 2017
Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell CarcinomaMaria F Becerra, Ed Reznik, Almedina Redzematovic, et al.
European Urology Focus|July 30, 2017
Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy SamplesYiyu Dong, Brandon J Manley, Maria F Becerra, et al.
Urologic Oncology|November 14, 2017
Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC)Derya Tilki, Thenappan Chandrasekar, Umberto Capitanio, et al.
Elife|March 30, 2019
Abnormal oxidative metabolism in a quiet genomic background underlies clear cell papillary renal cell carcinomaJianing Xu, Ed Reznik, Ho-Joon Lee, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 4, 2019
Association of an organ transplant-based approach with a dramatic reduction in postoperative complications following radical nephrectomy and tumor thrombectomy in renal cell carcinomaJavier González, Jeffrey J Gaynor, Juan I Martínez-Salamanca, et al.
Genome Biology|November 19, 2016
Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signaturesYasin Şenbabaoğlu, Ron S Gejman, Andrew G Winer, et al.
European Urology Open Science|October 3, 2025
An International Delphi Consensus About Tumor Rupture During Robotic Partial Nephrectomy (Researching UnPredictable TUmor RupturE during Robotic Partial Nephrectomy-The RUPTURE Project)Riccardo Bertolo, Alessandro Antonelli, Axel Bex, et al.
Cancer Cell|April 16, 2021
Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacyChirag Krishna, Renzo G DiNatale, Fengshen Kuo, et al.
Current Urology Reports|April 1, 2014
Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC)Juan I Martínez-Salamanca, Estefania Linares, Javier González, et al.
European Urology|July 23, 2013
Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombusDerya Tilki, Hao G Nguyen, Marc A Dall'Era, et al.
Pageof 36

Showing results (341-350 of 357) with videos related to

Sort By:
Pageof 36
European Urology Focus|October 26, 2017
Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell CarcinomaMaria F Becerra, Ed Reznik, Almedina Redzematovic, et al.
European Urology Focus|July 30, 2017
Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy SamplesYiyu Dong, Brandon J Manley, Maria F Becerra, et al.
Urologic Oncology|November 14, 2017
Impact of lymph node dissection at the time of radical nephrectomy with tumor thrombectomy on oncological outcomes: Results from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC)Derya Tilki, Thenappan Chandrasekar, Umberto Capitanio, et al.
Elife|March 30, 2019
Abnormal oxidative metabolism in a quiet genomic background underlies clear cell papillary renal cell carcinomaJianing Xu, Ed Reznik, Ho-Joon Lee, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 4, 2019
Association of an organ transplant-based approach with a dramatic reduction in postoperative complications following radical nephrectomy and tumor thrombectomy in renal cell carcinomaJavier González, Jeffrey J Gaynor, Juan I Martínez-Salamanca, et al.
Genome Biology|November 19, 2016
Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signaturesYasin Şenbabaoğlu, Ron S Gejman, Andrew G Winer, et al.
European Urology Open Science|October 3, 2025
An International Delphi Consensus About Tumor Rupture During Robotic Partial Nephrectomy (Researching UnPredictable TUmor RupturE during Robotic Partial Nephrectomy-The RUPTURE Project)Riccardo Bertolo, Alessandro Antonelli, Axel Bex, et al.
Cancer Cell|April 16, 2021
Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacyChirag Krishna, Renzo G DiNatale, Fengshen Kuo, et al.
Current Urology Reports|April 1, 2014
Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC)Juan I Martínez-Salamanca, Estefania Linares, Javier González, et al.
European Urology|July 23, 2013
Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombusDerya Tilki, Hao G Nguyen, Marc A Dall'Era, et al.
Pageof 36